The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases

The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases

With the continuous improvement of living standards but the lack of exercise, aging-associated metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are becoming a lingering dark cloud over society. Studies have found that metabolic disord...

Full description

Bibliographic Details
Main Authors: Junbin Yan, Yunmeng Nie, Jielu Cao, Minmin Luo, Maoxiang Yan, Zhiyun Chen, Beihui He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
fibroblast growth factor 21
aging
metabolic disease
glycometabolism
pharmacology
lipometabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.655575/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.655575/full

Similar Items